Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors
Condition: Tetanus, Diphtheria and Acellular Pertussis Vaccination Intervention: Biological: Tdap Sponsor: ABO Holdings, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2022 Category: Research Source Type: clinical trials